Monoclonal antibody targeting interleukin-6 achieves sustained reductions in inflammation biomarkers through six months

1 month ago 10

1. Homepage
2. Health
3. Monoclonal antibody targeting interleukin-6 achieves sustained reductions in inflammation biomarkers through six months